Mizuho lowered the firm’s price target on IN8bio (INAB) to $4 from $60 and keeps an Outperform rating on the shares. The firm continues to believe in IN8bio’s INB-100 program but adjusted the price target to reflect the 1-for-30 reverse stock split.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.